irenea……..I would like to share this: (I am sure to be corrected if stating anything wrong.) Oftentimes, the criteria are strict: No metastases, limited or, no prior chemotherapy, sometimes no multiple tumors or, sometimes tumors not exceeding a specific size. I have learned about some clinical trials where a controlled group of patients is being treated with a conventional therapy and the results are then compared to the control group receiving another drug or, another drug in addition to the conventional drug. For example: Group A receives 5FU and Leucovarin and Group B receives 5FU, Leucovarin and Oxyplatin. The results are then compared. However, a new drug for Cholangiocarcinoma would fall under the Orphan Drug status meaning: it is a rare disease affecting fewer than 200,000 patients or: less then 5 people per 10,000.
Can anyone fill me in about clinical trials? Must you be in the area in which study is being performed? Are these “free” because they are trials? Are they allowed to do studies in which we don’t know if we really receive the treatment or a placebo?